Stockreport

FDA Grants Appeal to Recro Pharma for IV Meloxicam New Drug Application

Recro Pharma, Inc.  (REPH) 
Last recro pharma, inc. earnings: 11/8 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.recropharma.com
PDF Received Positive Response from FDA Regarding IV Meloxicam Formal Dispute Resolution Request Company Remains on Track to Execute Spin Out of Acute Care Business Segme [Read more]